*** *****, ********* ** IPVM’s *********, ** ********, is *** ***** **************-********* proof ** ********** *********** manipulation. ***** * ******* represent ****** **** (****** or **********) *********** ********* in * ****** **** has ******** **** ***, unapproved ******* ******-***** ********* since *** *****-** ******** began.
*** ***** ***** ***** the * ******* (*** cleared) ******* ***** *** then *** * ****** devices:
***** ***** ****** ******* to ****** *********** ** highly ************ ***** ***** findings *** * **** to ****** ****** ***** they ******** ****** ****** as ******, ** *** study *****:
***** **** ***** ******* are ******** *** ******** detection ** ******** ********** disease ************, *** *** now ******** ********, *** implications *** ******* ********* of ********* *** * widespread ***** ***** ** security.
*** *********** ************* *** not ********* ** *************, work ** ********** ** clinical *****, *** ******** with *** ************ ** detecting ******. *********, *** study ****** ******* ********* over *** ********** ** temperature ********* ***** ****** the ********.
Study ***** ************ *********
** *** * *******, there **** ********** (*********) differences ******* ****** ******** and *** *******’* ***********. The *********** ********* ******** at ***** ************, *** decreased ******** ** ****** temperatures. ** ********, *** control ******* ****** ** such ***********; **** **** accurate *** ********** ****** all ****** ** *******.
*** ***** ***** ************ the ************ ******* ***** across ****** *******:
***** ** * *********** analysis ** ***** ***********, the ***** ********* **** they ****** **** * software-based ************ *********. *** algorithm ******* ************ ******* the ***** ****, ******* the ****** (** *****) the ***********, *** ****** the **********. ** ****** in *** *****:
***** ********, ***** ******** suggest * *****-****** ******** algorithm **** ******* *** recorded *********** ** *** human ****, **** *** strongest *********** ******* ** the **** ******* ********.Thus, * ***** ******* ******* ***** ****** ** ******** ** ****. [emphasis added]
FDA **********
** *** **, *** FDA ********* ***** *********** screening ******** ** ******* devices. **********, *** ****** requires **** *** *** devices *** ****** *** safety *** *************; **** is ***** ** * 510 (*) *********. ***** ***** ****, *** FDA ********* **** **** "*** *** intend ** ******" ** the ***** ** ********* products ** ***** *** no "***** ****".
********* *** ***’* ************, a ***** ** ******** temperature ********* **** ******** to ******. ** ****’* most ****** *****, ***** are *** **** **** *** sellers . ****** *** ******* the *********** ********* ****** during *** ********.
FDA ********
***** ********** **** ********* , *** *** *** taken *** ***** ******:
** ******** *****, ******* after *** ********** **** discussed *** ******** ******** with *** **** *** Drug **************, *** ****** issued ******* ***** ******* **** ******** *** of *** ******* ***** lead ** ********** ************ and “******* *********** ******* public ****** *****.”
*** ******** *** ******* what ***** ****** **** the *** *** ***** regulatory ******** ****** *** world **** ** *** issues **** ***** ******* become ****** **********.
Update (**/**/**): ********* ********
********* *** ********* ** the *****, ******:
** ***** **** ** emphasize **** *** ********* DS-2TD2636B-13/P **** *** ********** temperature ******** ** ****** by ****. *** ****** uses * *********** ************ algorithm ** ****** *** measured **** *********** ** align **** *** ******** body ***********, ***** ** common ** ******** **** thermal ******* *************.
********* ********** **** *** compensation ********* “** **** for *** ********* *********** screening ******* *******.” ********* also **** ***** **** IPVM’s ****** *********** ** their ****** ***** * -1.6°C ******:
***** *** ******** ** the ********* ****** ** ±0.5ºC, ***** ** ****** of -*.*º* **** ****** the *********** ** *** technology **********. ** *** not ******** **** *** IPVM ********** *** ******, but ** ******* **** correct *********** ***** **** resulted ** **** ******* closer ** *** ******* devices ********* ** **** study.
****’* ****** *********** *** based ** ************ ***** by ********* ** ****. Their ************ **** ** offset *** ******* ** the ***** **** **°* when *** ****** ********* outside *** ******** ***** measuring * ***** **** at **°*. ** ***** in *** *****'* *******, with * -*.*°* ****** the ****** **** **°* with *** ***** **** at **°*. ********, ** fixed ****** ***** ***** impact *** ******* ** the *****. ** ***** merely ***** *** ********* camera’s *******, *** *** change *** ********** *********** values ********** **** ****.
Comments (26)
John Honovich
**** ** * ********** of * *-***** ******* which, ** ******* ****, grew *** ** ** approaching ***-**** **-***** ****** to**** (****** ** *******) **** ******* ************** into ******* *******.
* ** **** ***** are ***** ** ** lots ** ********* (********* ones, ** **********). ** are ***** ** ****** them ****** ** ***** take * *** ****, as *** *********** ** this *** ***** ** due ** ****** **** the ********** ****, *** interviews **** *** ***, etc.
****** ** *** **** - ** ********** *****, Derek, *****, **** *** spent ** **** **** on *** ***** - and ** *** ** you *** **** ********* for **** ******* *** proper *** ** **** technology.
Create New Topic
Erik Beall
***, ***** **** **** and ** ******* ** published. * **** ******* to *** **** ********** Optics.
Create New Topic
Erik Beall
** *** ****, ** this *** ********** ** the **** ****** ** something **** (***** **** combined **** *** **** difference **** *******)? *** how *** *** *** the ******** **** **-***, were ***** ***** ******** with * ***** ** different ************?
Create New Topic
John Honovich
*********** ******* ** *** WaPo ******* ***** *** a ********* ******** ** stood ******* ** *** cold ** **** *** temperature ********* ***** ** was ******* * ****** fever:
Create New Topic
Undisclosed Distributor #1
***** ******* ***** ****** are ** *** **** are ******** *********. **** should *** ** *********** recalled & *** **** suckers *** ****** **** be ***** ***** ***** back.
*** ****** ***** ****** be ****** & *** person ********, ******* ** importing **** **** ******** charges
Create New Topic
Undisclosed Manufacturer #2
**'* **** ******* **** the ******** **** ******** of ******* ***** ** these ******* ** *** last **** *** ***** implementation **** ***** ***** a ***-*********** ******* **** the ****** *********, *********, but *** ******* ** a ********* **** **** by * *** ********* device.
***** **** **** ******** to ******** ********* *** implied "*********" ** *** part ** *** *** user ** ******* **** negligence ** **** ** the ************, ******, ********* and *****.
*********: * *** ***** from **** ** *** office **** * ***** the *** ** *** conference **** **** ***. I've **** ** *** hospital ** * ********** for * ******, **** my ***, *****, ********** and * **** **** in ******* *****.
*** ***** *******: *** can *** ***** *** got ** **** ****?
Defendant: * *** ****** ** **** ** *** ******. * **** ***** ********** *** ****** *** *** **********. **** **** *** ***** *** *** ** *** **** ***** ** *** ******** *******. ****, ** *** ********* **** ***** * **** ***** **** ** *** ****** ** * ******** ** ** *********.
*** ***** *******: **** the *********** (******* *** want ** *** ** the ***** ** *** corporation) ********* * ***** detection ****** **** ******** must **** *******, ** it's ********** **** *** got **** **** **** as *** ***** ********* System ****** ***** **** denied **** ****** ** the ********.
*********: *** ****, *** system *** ********* ** not *** ******** ***/**/*** was ** ********* ********.
***** ****** ******* (***** of ****) ** ******* for *** *********.
**** * *****! * sure **** ***** ** our ******** ******* ******** *** **** **** liability
***** **** *********. *** or **** ******* *** not ** ******* *** intentional **********.
Create New Topic
Undisclosed Manufacturer #2
*** ***'* ********* **** to **** * ******** temperature ** **** *****.
***** ******* ********** (** the **** ** *** end ****) ** ******, the **** **** *** end **** ********* **** system **** *** ***** intent ** ****** *** ultimately ******* **** *************** ******* ********* ** those ************ ******* ******* the ******* ************ **** **** ** fact ***** **** *********** along **** *** ***** previous ********** *******. (*.*. no ******* ****** ***** cameras).
*** **** **** **** was ********** ********* (*** hospitalized **** * ******** COVID *********) * **** later ** **** ** a ****~ ** **** or **** ***** ***** that **** *** ***** post ***** ********* ****** and *** ** ****** carrier **** ** *** with *** *********.
* ********* *** ***** Detection ****** ****** ** detect (******* ** *********), which ** *** **** basis *** ***** ********* promotion - ***** *********. Yes **** ***** **** implied ** *** ***** detection, *** *** *** messaging **** ** ******.
***** ** ** ***** immunity *** ***** ******* or *** ********* *********** their **************, ****** *** vaccine *********.
* ***** *** *********'* chances ** * ********* ruling ** * **** trial ** * *****. It *** ***** **** hill *** *** * parties **** ** *** bottom *** *** **********/********* and *** ************, ************. Good ****!
***, *'* *** * lawyer, *** * **** be ** ****** ******* if ** **** ******.
Create New Topic
Undisclosed Integrator #4
*** *** ***** *** story ** *** ****, Certify ****** * ***** device *** *** ******:
******** ******* '*******' * fever ******* ***** *** warning - *** ********** Post
Create New Topic
LUIS PINZON
*************** **** ****.
Create New Topic
John Honovich
*** ******* ** ********** Optics *** *** ********* the *****: "******** ******** *****-** ***** screening ******* ***** ******** thermographs ************ ********* **** readings ** ******** *****":
Create New Topic
Josh Leverett
** *** **** ** OEM **** ** ***** devices ** ** *** figure *** **** ****** of ******* *** ********?
Create New Topic
Conor Healy
**** ****** *** **** updated **** *********'* ******** to *** *****.
Create New Topic